Onodera H | Pharmaceuticals And Medical Devices Agency
スポンサーリンク
概要
関連著者
-
Onodera Hiroshi
東京都健康安全研究センター
-
Onodera Hiroshi
Pharmaceuticals And Medical Devices Agency
-
小野寺 博志
Division Of Pathology National Institute Of Health Sciences
-
Kitamura Y
Division Of Pathology National Institute Of Health Sciences
-
Yasuhara Kazuo
Division Of Pathology National Institute Of Health Sciences
-
ONODERA Hiroshi
Division of Pathology, National Institute of Health Sciences
-
Mitsumori Kunitoshi
Division Of Pathology National Institute Of Health Sciences
-
Yasuhara Kazuo
Divisions Of Toxicology National Institute Of Hygienic Sciences
-
MITSUMORI Kunitoshi
Division of Pathology, National Institute of Health Sciences
-
Takagi Hisayoshi
国立医薬品食品衛生研究所
-
Takagi Hisayoshi
Division Of Pathology National Institute Of Health Sciences
-
TAKAGI Hisayoshi
Division of Pathology, National Institute of Health Sciences
-
Hirose Masao
Division Of Pathology National Institute Of Health Sciences
-
Takizawa Tamotsu
Division Of Pathology National Institute Of Health Sciences
-
Hirose Masao
国立医薬品食品衛生研究所 病理
-
Hirose Masao
Division of Pathology, National Institute of Health Sciences
-
Hirose Masao
Div. Pathol. Natl. Inst. Htlh. Sci.
-
Yasuhara K
Division Of Pathology National Institute Of Health Sciences
-
Takizawa Tamotsu
東京農工大学
-
Kodama Yukio
Division Of Pathology National Institute Of Health Sciences
-
Takizawa Tamotsu
Division Of Pathology National Institute Of Health
-
TAMURA Toru
Division of Pathology, National Institute of Health Sciences
-
Takegawa Kiyoshi
Division of Pathology, National Institute of Health Sciences
-
Takegawa K
Division Of Pathology National Institute Of Health Sciences:safety Evaluation Drug Development Labor
-
Takegawa Kiyoshi
三菱ウェルファーマ
-
Takada Koichi
Safety Evaluation Laboratory Yoshitomi Pharmaceutical Industries Co. Ltd.
-
Takegawa K
Toxicology Laboratories Pharmaceutical Research Division Mitsubishi Pharma Corporation
-
Takegawa Kiyoshi
Department Of Pathology National Institute Of Health Sciences
-
Takegawa Kiyoshi
Safety Evaluation Drug Development Laboratories Pharmaceutical Research Division Yoshitomi Pharmaceu
-
Takada Koichi
国立医薬品食品衛生研究所
-
Ueda Makoto
Division Of Pathology National Institute Of Health Sciences
-
Tamura Toru
Division Of Pathology National Institute Of Health Sciences
-
糀谷 高敏
Division Of Pathology National Institute Of Health Sciences
-
Koujitani Takatoshi
国立医薬品食品衛生研究所
-
Tamura Tomohide
Medical Oncology Division National Cancer Center Hospital
-
ONODERA Hiroshi
Div. of Pathol. National Institute or Health Sciences
-
YASUHARA Kazuo
Div. of Pathol. National Institute or Health Sciences
-
安原 加壽雄
San-ei Gen F.f.i. Inc.
-
Mori H
Division Of Pathology National Institute Of Health Sciences
-
UEDA Makoto
Division of Pathology, National Institute of Health Sciences
-
MITSUMORI Kunitoshi
Div. of Pathol. National Institute or Health Sciences
-
Mitsumori Kunitoshi
東京大学医科学研究所 癌細胞シグナル分野
-
Shimo T
National Inst. Health Sci. Tokyo
-
Kurokawa Y
Division Of Toxicology National Institute Of Health Sciences
-
Shimo Takeo
Division of Pathology, National Institute of Health Sciences
-
Shimo Takeo
Division Of Pathology Biological Safety Research Center National Institute Of Health Sciences
-
Makita Hiroki
岐阜大学 第1病理
-
今井 淑夫
Division Of Pathology National Institute Of Health Sciences
-
今井 淑夫
東京工業大学部有機材科工学科
-
Imai Toshio
Division of Pathology, National Institute of Health Sciences
-
TAKIZAWA Tamotsu
Division of Pathology, National Institute of Health Sciences
-
HIROSE Masao
Div. Pathol, Natl. Inst. Hlth. Sci.
-
Mitsumori Kunitoshi
Department Of Pathology National Institute Of Health Sciences
-
Koujitani Takatoshi
Division Of Pathology National Institute Of Health Sciences
-
Hayashi Y
National Inst. Health Sci. Tokyo
-
Hayashi Yuzo
Department Of Pharmaceutical Sciences Kitasato University
-
Takahashi M
National Inst. Health Sci. Tokyo
-
Kitaura K
Univ. Tokushima School Of Medicine Tokushima
-
Kai Shuichi
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufacturers As
-
Kai Shuichi
東京都健康安全研究センター
-
Kai Shuichi
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufacturers As
-
Sagami Fumio
第一三共安全性研究所
-
Sagami Fumio
Drug Safety Research Laboratories Eisai Co. Ltd.
-
Sagami Fumio
Subcommittee Of Non-clinical Evaluation Drug Evaluation Committee Japan Pharmaceutical Manufacturers
-
Sagami Fumio
Department Of Drug Safety Research Eisai Kawashima Research Laboratories Eisai Co. Ltd.
-
Mitsumori Kunitoshi
Toxicology Division Institute Of Environmental Toxicology
-
Hirose Masao
名古屋市立大学 医学研究科実験病態病理学
-
Koujitani Takatoshi
Division of Pathology, National Institute of Health Sciences, 1-18-1, Kamiyoga, Setagaya-ku, Tokyo 1
-
Tamura Toru
Toxicology Research Laboratory R & D Kissei Pharmaceutical Co. Ltd.
-
Watanabe Takao
Laboratory Of Veterinary Pathology Faculty Of Agriculture Tokyo University Of Agriculture And Techno
-
TAKEGAWA Kiyoshi
Div. of Pathol. National Institute or Health Sciences
-
TAKAHASHI Michihito
Div. of Pathol. National Institute or Health Sciences
-
Shinoda Kazutoshi
Pharmaceuticals and Medical Devices Agency
-
MITSUMORI Kunitoshi
Laboratory of Veterinary Pathology, Tokyo University of Agriculture and Technology
-
Mitsumori Kunitoshi
国立医薬品食品衛生研究所 病理部
-
WATANABE Takao
Laboratory of Veterinary Pathology, Tokyo University of Agriculture and Technology
-
Inoue Tohru
Biological Safety Research Center, National Institute of Health Sciences
-
Matsui Takane
国立医薬品食品衛生研究所
-
Matsui Takane
United Graduate School Of Veterinary Sciences Gifu Unicersity
-
Mitsumori Kunitoshi
Laboratory Of Veterinary Pathology Division Of Animal Science Institute Of Symbiotic Science And Tec
-
TAKAHASHI Masakazu
Department of Pathology, Sasaki Institute
-
Satake M
Institute Of Environmental Science For Human Life Ochanomizu University
-
Sekita Setsuko
Division Of Pharmacognosy And Phytochemistry National Institute Of Health Sciences
-
Hirota M
Department Of Bioscience And Biotechnology Faculty Of Agriculture Shinshu University
-
Kawai Mutsufumi
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufacturers As
-
KAI Shuichi
Non-clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufactures A
-
SAGAMI Fumio
Non-clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufactures A
-
Matsui Hajime
Division Of Pathology National Institute Of Health Science
-
高橋 通正
(独)産業技術総合研究所 環境管理技術研究部門
-
Kai Shuichi
ブリストルマイヤーズスクイブ
-
Sagami Fumio
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufacturers As
-
Sagami Fumio
Japan Pharmaceutical Manufacturers Association (jpma) Qt Prodact
-
Mitsumori Kunitoshi
東京農業大学
-
KASHIDA Yoko
Laboratory of Veterinary Pathology, Tokyo University of Agriculture and Technology
-
Mitsumori K
Laboratory Of Veterinary Pathology Tokyo University Of Agriculture And Technology
-
Mitsumori Kunitoshi
東京農工大学 獣医学科
-
Hirose M
Division Of Pathology National Institute Of Health Sciences:food Safety Commission
-
Mitsumori Kunitoshi
杏林製薬研究センター
-
Hayashi Yuzo
Department of Pharmaceutical Sciences, Kitasato University, 5-9-1, Shirogane, Minato-ku, Tokyo 108-0
-
Hayashi Yuzo
Department Of Cardiology Nagoya University Graduate School Of Medicine
-
Ohno Yasuo
第一三共安全性研究所
-
MATSUI Takane
United Graduate School of Veterinary Sciences, Gifu Unicersity
-
Kawashima Kunio
Division of Toxicology, National Institute of Health Sciences
-
Maita K
The Institute Of Environmental Toxicology:agrotox Inc.
-
Ohno Yasuo
National Institute of Health Sciences
-
SATAKE Motoyoshi
Division of Pharmacognosy and Phytochemistry, National Institute of Health Sciences
-
MITSUMORI Kunitoshi
Institute of Environmental Toxicology
-
Sekita Setsuko
大阪府立公衆衛生研究所
-
Sekita Setsuko
National Institute Of Health Sciences
-
Ozaki Yukihiro
Division Of Pharmacognosy And Phytochemistry National Institute Of Health Sciences
-
Nakazawa Takahiro
Japan Pharmaceutical Manufacturers Association, Drug Evaluation Committee, Non-clinical Evaluation S
-
Kurokawa Misao
Japan Pharmaceutical Manufacturers Association, Drug Evaluation Committee, Non-clinical Evaluation S
-
Kawamura Nobuyuki
European Federation of Pharmaceutical Industries and Associations
-
Yamazaki Tsuneyoshi
Kyoritsu University of Pharmacy, Kyoritsu University of Pharmacy
-
Fueki Osamu
Pharmaceuticals and Medical Devices Agency
-
今井 淑夫
元 東京工業大学工学部有機材料工学科
-
Inoue Tohru
Biological Safety Res. Center National Inst. Of Health Sciences
-
Imai Yoichiro
Department Of Clinical Biochemistry Fujita Health University College
-
Nara Yasuo
Department Of Pharmacy School Of Pharmacy Shujitsu University
-
Mitsumori Kunitoshi
Laboratory Of Veterinary Pathology Tokyo University Of Agriculture And Technology
-
FURUKAWA Fumio
Division of Pathology, National Institute of Health Sciences
-
KODAMA Yukio
Division of Toxicology, National Institute of Health Sciences
-
Kitajima Satoshi
Department Of Environmental Health And Toxicology Tokyo Metropolitan Institute Of Public Health
-
Satoh Kanako
東京都健康安全研究センター 環境保健部
-
Satoh Kanako
Department Of Environmental Health And Toxicology Tokyo Metropolitan Institute Of Public Health
-
Nakae Dai
東京都健康安全研究センター
-
Nakae Dai
Tokyo Metropolitan Institute Of Public Health
-
YANAI Tokuma
Department of Veterinary Pathology, Gifu University
-
MASEGI Toshiaki
Department of Veterinary Pathology, Gifu University
-
MUTAI Mamoru
Toxicology Laboratory, Life Science Research Sector, Mitsubishi Chemical Co. Yokohama Research Cente
-
FUJIMOTO Nariaki
Department of Cancer Research, Hiroshima University
-
Tamura T
Division Of Internal Medicine National Cancer Center Hospital
-
YAMADA Tomoya
Environmental Health Science Laboratory, Sumitomo Chemical Co., Ltd.
-
三森 国敏
Laboratory Of Veterinary Pathology Tokyo University Of Agriculture And Technology
-
Shirao Kuniaki
Gastrointestinal Oncology Division National Cancer Center Hospital
-
Sai Kimie
Divislon Of Toxicology National Institute Of Health Sciences
-
Sai-kato Kimie
Division Of Toxicology
-
Shimo Takeo
Department Of Pathology National Institute Of Health Sciences
-
Tamura Tomohide
国立がんセンター中央病院 腫瘍内科
-
Tamura T
National Cancer Center Hospital Tokyo
-
Takegawa Kiyoshi
Toxicology Lab. Mitsubishi Pharm.
-
林 裕造
Department Of Pharmaceutical Sciences Kitasato University
-
HIROSE Masao
Div.Pathol., Natl.Inst.Health Sci.
-
Tagawa Toshiaki
国立がんセンター中央病院 消化器内科
-
三森 国敏
Division of Pathology, National Institute of Health Sciences
-
安原 加壽雄
Division of Pathology, National Institute of Health Sciences
-
森 郁生
Hikari Branch, Drug Safety Research Laboratories, Takeda Chemical Industries, Ltd.
-
野々山 孝
Hikari Branch, Drug Safety Research Laboratories, Takeda Chemical Industries, Ltd.
-
KUROKAWA Yuji
Division of Toxicology
-
Saito Minoru
Division of Toxicology, National Institute of Health Sciences
-
Tanaka Satoru
Division of Toxicology, National Institute of Health Sciences
-
TAKADA Koichi
Division of Toxicology, Biological Safety Research Center, National Institute of Hygienic Sciences
-
TAKANAKA Akira
Division of Pharmacology, BSRC, National Institute of Hygienic Sciences
-
Sekita Kiyoshi
Division Of Cellular & Molecular Toxicology National Institute Of Health Sciences
-
Hoshi Manabu
大阪市立大学 医学部病理学
-
TANAKA Satoru
Toxicology Laboratory, Kissei Pharmaceutical Co., Ltd.
-
Furukawa Fumio
Division Of Pathology National Institute Of Health Sciences
-
INOUE Tadashi
Japan Pharmaceutical Manufactures Association
-
WATANABE Tomoyuki
Environ. Health Science Lab., Sumitomo Chem. Co., Ltd.
-
FURUNO Nobuaki
Institute for Amphibian Biology, Graduate School of Science, Hiroshima University
-
SHIMADA Akinori
Department of Veterinary Pathology, Tottori University
-
KITAJIMA Satoshi
Division of Cellular and Molecular Toxicology, BSRC, National Institute of Health Sciences
-
Kimura Kazuya
Japan Pharmaceutical Manufacturers Assoc. Drug Evaluation Committee Non-clinical Evaluation Subcommi
-
Furuno Nobuaki
Institute For Amphibian Biology Graduate School Of Science Hiroshima University
-
Hisada Shigeru
Safety Research Department Developmental Research Center, ASKA Pharmaceutical Co., Ltd.
-
HISADA SHIGERU
Japan Pharmaceutical Manufacturers Association
-
WAKATA AKIHIRO
Japan Pharmaceutical Manufacturers Association
-
OZAKI Yukihiro
Division of Pharmacognosy and Phytochemistry, National Institute of Health Sciences
-
ONODERA Hiroshi
Department of Pathology, National Institute of Health Sciences
-
YASUHARA Kazuo
Department of Pathology, National Institute of Health Sciences
-
KITAURA Keisuke
Department of Pathology, National Institute of Health Sciences
-
TAKAHASHI Michihito
Department of Pathology, National Institute of Health Sciences
-
MAEKAWA AKIHIKO
Department of Pathology, Sasaki Institute
-
Saito Minoru
Division Of Cellular & Molecular Toxicology National Institute Of Health Sciences
-
Mutai Mamoru
Toxicol.lab.life Sci.res.sect.mitsubishi Chemical Co. Ltd.
-
Saito Masako
Department Of Applied Physics University Of Tokyo:(present Address)institute For Solid State Physics
-
Sekita S
Division Of Pharmacognosy Phytochemistry And Narcotics National Institute Of Health Sciences
-
Yoshida Takemi
Showa Univ.
-
Hisada Shigeru
Safety Research Department Developmental Research Center Aska Pharmaceutical Co. Ltd.
-
Hisada Shigeru
Safety Research Department Aska Pharmaceutical Co. Ltd.
-
Heidel Shawn
Eli Lilly, Eli Lilly and Company
-
Kawakami Koji
Kyoto University
-
Kumagai Yuji
Showa University, School of Pharmaceutical Sciences
-
Inoue Tohru
National Institute of Health Sciences
-
Onodera Horoshi
Pharmaceuticals and Medical Devices Agency
-
Urano Tsutomu
Pharmaceuticals and Medical Devices Agency
-
Komiyama Noriyuki
Pharmaceuticals and Medical Devices Agency
-
Nishimura Chihiro
Non-clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers
-
NAITO Shinsaku
Japan Pharmaceutical Manufacturers Association, Drug Evaluation Committee, Non-clinical Evaluation S
-
FURUTA Shigeru
Japan Pharmaceutical Manufacturers Association, Drug Evaluation Committee, Non-clinical Evaluation S
-
KITADA Mitsukazu
Chiba University Hospital
-
UNNO Takashi
Pharmaceutical Research and Manufactures of America
-
NAKAZAWA Takahiro
Non-clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers
-
KAWAI Mutsufumi
Non-clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers
-
MAKI Eiji
Non-clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers
-
森 郁生
Drug Analysis And Pharmacokinetics Research Laboratories Takeda Chemical Industries Ltd.
-
Usami Makoto
Division of Pharmacology, National Institute of Health Sciences
-
Maki E
Japan Pharmaceutical Manufacturers Assoc. Tokyo Jpn
-
Yanai Tokuma
Department Of Veterinary Pathology Faculty Of Agriculture Gifu University
-
Tamura Tomohide
Division Of Internal Medicine National Cancer Center Hospital
著作論文
- Comparison of enhancing effects of different goitrogen treatments in combination with β-estradiol-3-benzoate for establishing a rat two-stage thyroid carcinogenesis model to detect modifying effects of estrogenic compounds
- LACK OF MODIFYING EFFECTS OF EUGENOL ON DEVELOPMENT OF LUNG PROLIFERATIVE LESIONS INDUCED BY URETHANE IN TRANS-GENIC MICE CARRYING THE HUMAN PROTOTYPE c-Ha-ras GENE
- Inhibiting Effects of Ethinylestradiol on N-ethyl-M-nitrosourea-Initiated Uterine Carcinogenesis in Transgenic Mice Carrying a Human Prototype C-Ha-ras Gene (rasH2 mice) (CARCINOGENICITY) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th A
- Promoting Effects of Ethinylestradiol but not Atrazine on N-ethyl-N-nitrosourea-induced Uterine Carcinogenesis in ICR Mice
- Difference in the Types of Uterine Tumors between Heterozygous p53-deficient and Wild Type CBA Mice Treated with Ethinylestradiol after N-ethyl-N-nitrosourea Initiation
- Modifying effect of atrazine on DMBA-induced mammary carcinogenesis in ovariectomized rats.(GENERAL SESSION BY POSTER PRESENTATION)(CARCINOGENICITY)
- Modifying Effects of Genistein, 4-Nonylphenol and Methoxychlor on N-ethyl-N-nitrosourea-induced Uterine Carcinogenesis in RasH2 Transgenic Mice Harboring a Human Prototype C-Ha-ras Gene
- Enhancing Effects β-Estradiol 3-Benzoate but Not Methoxychlor on the Promotion/Progression Stage of Chemically-induced Mammary Carcinogenesis in Ovariectomized Rats
- GONADAL TOXICITY OF AN ETHANOL EXTRACT OF PSORALEA CORYLIFOLIA IN A RAT 90-DAY REPEATED DOSE STUDY
- The Utility of N-nitrosamines as Initiators for a 26-Week Rat Two-Stage Nasal Carcinogenesis Model
- "C-6 Evaluation of Rat Hepatotoxicity on Benzimidazole Compounds Using Gap Junctional Intercellular Communication Protein, Connexin 32.
- Induction of Squamous Cell Carcinomas in the Salivary Glands of Rats by Potassium Iodide
- Possible enhancing effects of atrazine on growth of 7, 12-dimethylbenz(a) anthracene-induced mammary tumors in ovariectomized Sprague-Dawley rats
- Safety assessment of biopharmaceuticals : Japanese perspective on ICH S6 guideline maintenance
- Points to consider on the non-clinical safety evaluation of anticancer drugs
- CURRENT OPINION : SAFETY EVALUATION OF DRUG METABOLITES IN DEVELOPMENT OF PHARMACEUTICALS
- "POINTS TO CONSIDER" REGARDING SAFETY ASSESSMENT OF BIOTECHNOLOGY-DERIVED PHARMACEUTICALS IN NON-CLINICAL STUDIES (ENGLISH TRANSLATION)
- MECHANISTIC STUDY ON INHIBITION OF SERUM THYROID HORMONE PRODUCTION BY THIOUREA
- THYROID PROLIFERATIVE LESIONS INDUCED BY ANTI-THYROID DRUGS IN RATS ARE NOT ALWAYS ACCOMPANIED BY SUSTAINED INCREASES IN SERUM TSH
- TIME COURSE OBSERVATION OF THYROID PROLIFERATIVE LESIONS AND SERUM LEVELS OF RELATED HORMONES IN RATS TREATED WITH KOJIC ACID AFTER DHPN INITIATION
- IMMUNOHISTOCHEMICAL STUDIES OF TSH-PRODUCING CELLS IN THE PITUITARY AND EXPRESSION OF GROWTH FACTORS IN THYROIDAL PROLIF-ERATIVE LESIONS IN RATS TREATED WITH THIOUREA AND EXCESS VITAMIN A
- "P-42 Protective Effect of Lecithinization-Superoxide Dismutase Against Monocrotaline Induced Lung Injuries
- "P-41 A Morphometric study on the time course change of thyrotroph hypertrophy in the pituitary of rats treated with a goitrogen.
- Lack of Modifying Effects of NNK on Lung Tumorigenesis in Hamsters with Pulmonary Fibrosis Induced by MNUR
- DOSE-THRESHOLD FOR THYROID TUMOR-PROMOTING EFFECTS OF ORALLY AMINISTERED KOJIC ACID IN RATS AFTER INITIATION WITH N-bis(2-HYDROXYPROPYL) NITROSAMINE
- CAPACITY FOR INDUCTION OF THYROID PROLIFERATIVE LESIONS BY ANTI-THYROID DRUGS WITH DIFFERENT TOXIC MECHANISMS
- TIME COURSE OBSERVATION OF THYROID PROLIFERATIVE LESIONS AND SERUM TSH LEVELS IN RATS TREATED WITH THIOUREA AFTER DHPN INITIATION
- RELATIONSHIP BETWEEN INDUCTION-DOSES OF THYROID TUMORS BY ANTI-THYROID DRUGS AND PLASMA LEVELS OF T_3, T_4 AND TSH
- P-39 Effect of t-buthylhydroquinone and sodium nitrite alone or in combination on the forestomach of rasH2 mice.(Proceedings of the 27th Annual Meeting)
- P-38 Carcinogenic susceptibility of phenolphthalein in heterozygous p53 deficient C57BL/6 and CBA mice.(Proceedings of the 27th Annual Meeting)
- TOXICITY AND BLOOD CONCENTRATIONS OF XYLAZINE AND ITS METABOLITE, 2, 6-DIMETHYLANILINE, IN RATS AFTER SINGLE OR CONTINUOUS ORAL ADMINISTRATIONS
- 21C-11-2 Modifying Effects of Xylazine on Rat Nasal Carcinogenesis.
- 21WA-01-4 Modifying Effects of Endocrine Disrupting Chemicals to Thyroid Proliferative Lesions in Ovariectomized Rats.
- Absence of Tumor Promoting Activity of Xylazine in a Two-stage Nasal Carcinogenesis Model in N-bis(2-hydroxypropyl)nitrosamine-treated Rats
- O11-12 Modifying effects of endocrine disrupting chemicals on ENU-induced uterine carcinogenesis in heterozygous p53 deficient CBA mice.
- P-67 Early changes of thyroid and in rats given a single administration of diisopropanolnitrosamine.(Proceedings of the 27th Annual Meeting)
- O-14 Mechanistic studies on testicular toxicity of Psoralea corylifolia extract in rats.(Proceedings of the 27th Annual Meeting)
- 21C-10-3 Susceptibility of p53 heterozygous knockout CBA mice to carcinogenic substances.
- 3A-19 A Mechanistic Study on Ovarian Carcinogenesis of Nitrofurazone in Mice
- 3A-16 Toxicological significance of the metabolite, 2,6-xylidine, in rats treated with a parent drug, xylazine
- 3A-06 Study on the Thyroid Tumor Promotion Effect of Kojic Acid
- CONFIRMATION STUDY, USING NITROBENZENE, OF THE COMBINED REPEAT DOSE AND REPRODUCTIVE/DEVELOPMENTAL TOXICITY TEST PROTOCOL PROPOSED BY THE ORGANIZATION FOR ECONOMIC COOPERATION AND DEVELOPMENT (OECD)
- Prevention of Stroke by a Japanese Traditional Medicine, Shichimotsu-koka-to, in Stroke-Prone Spontaneously Hypertensive Rats-a Histopathological Study
- Preventive Effects of Shinchimotsu-koka-to on Renal Lesions in Stroke-Prone Spontaneously Hypertensive Rats
- MORPHOLOGICAL EVALUATION OF CYCLOPHOSPHAMIDE TESTICULAR TOXICITY IN RATS USING QUANTITATIVE MORPHOMETRY OF SPERMATOGENIC CYCLE STAGES
- TESTICULAR TOXICITY EVALUATION OF CYCLOPHOSPHAMIDE BY QUANTITATIVE MORPHOMETRY OF SPERMATOGENIC CYCLE STAGES
- EFFECTS OF BARBITAL ON NEURO-ONCOGENESIS IN A TRANSPLACENTAL CARCINOGENICITY MODEL USING F344 RATS
- STUDY OF EXAMINATION METHODS FOR ASSESSING MALE FERTILITY DISTURBANCES 1.QUANTITATIVE MORPHOMETRICAL EVALUATION OF TESTICULAR TOXICITY OF ADRIAMYCIN
- SPONTANEOUS MESOTHELIOMAS IN F344 RATS : A LIGHT AND ELECTRON MICROSCOPICAL STUDY
- Prevention of Stroke by a Japanese Traditional Medicine, Shichimotsu-koka-to, in Stroke-Prone Spontaneously Hypertensive Rats : a Histopathological Study
- Perspectives on non-clinical safety evaluation of drug metabolites through the JSOT workshop
- Susceptibility of Heterozygous p53 Deficient CBA Mice to Induction of Liver Proliferative Lesions by Phenobarbital after Dimethylnitrosamine Initiation
- Modifying Effects of Flumequine on Dimethylnitrosamine-Induced Hepatocarcinogenesis in Heterozygous p53 Deficient CBA Mice